Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

HIK

Kedudukan dalam Saham #25461
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Harga Saham
$22.60
Modal Pasaran
$46.79M
Perubahan (1 hari)
0.42%
Perubahan (1 tahun)
-52.40%
Negara
GB
Perdagangan Hikma Pharmaceuticals PLC (HIK)

Kategori

Healthcare
Harga HIK dengan permodalan pasaran b
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
HIK
$22.60
Modal pasaran bagi Hikma Pharmaceuticals PLC(HIK)
Modal Pasaran: $46.79M
Sehingga October 2026, Hikma Pharmaceuticals PLC mempunyai modal pasaran sebanyak $46.79M. Ini menjadikan Hikma Pharmaceuticals PLC syarikat ke-25461st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Hikma Pharmaceuticals PLC dari 2011 hingga 2026
HIK berbanding dengan 5 teratas yang paling popular stocks
Harga HIK Aset B Pasaran B Hasilnya
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$49,930.70 $4.60B
$5.167T +112,331.21%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$48,459.36 $4.60B
$5.015T +109,018.12%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$39,700.76 $4.60B
$4.108T +89,295.98%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$37,705.30 $4.60B
$3.902T +84,802.72%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$25,989.04 $4.60B
$2.689T +58,420.70%